MECHANISMS OF ACTION OF AMINOGLUTETHIMIDE AS ENDOCRINE THERAPY OF BREAST-CANCER

被引：112

作者：

LONNING, PE

KVINNSLAND, S

机构：

来源：

关键词：

D O I：

10.2165/00003495-198835060-00005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：685 / 710

页数：26

共 221 条

[1] ABOULENEIN A, 1983, 2ND INT C HORM CANC
[2] ABULHAJJ YJ, 1982, CANCER RES, V42, P3373
[3] THE EFFECT OF ACETYLATOR PHENOTYPE ON THE DISPOSITION OF AMINOGLUTETHIMIDE
ADAM, AM
ROGERS, HJ
AMIEL, SA
RUBENS, RD
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (04) : 495 - 505
[4] ADAM AM, 1985, CANCER CHEMOTH PHARM, V15, P176
[5] AHMANN FR, 1987, CANCER RES, V47, P4736
[6] A CLINICAL-TRIAL OF AMINOGLUTETHIMIDE IN ADVANCED POSTMENOPAUSAL BREAST-CARCINOMA - LOW RESPONSE IN PATIENTS PREVIOUSLY TREATED WITH MEDROXYPROGESTERONE
ALBERTO, P
MERMILLOD, B
KAPLAN, E
GOLDHIRSCH, A
OBRECHT, JP
JUNGI, F
MARTZ, G
BARRELET, L
CAVALLI, F
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (04): : 423 - 428
[7] APPELGREN LE, 1985, 2ND SCAND BREAST CAN
[8] ASBURY RF, 1981, CANCER, V47, P1954, DOI 10.1002/1097-0142(19810415)47:8<1954::AID-CNCR2820470807>3.0.CO
[9] 2-E
[10] BAKER MH, 1981, BRIT J PHARMACOL, V74, P243